2015年版較2009年版ATA指南對甲狀腺乳頭狀癌的手術治療變化及解讀_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 程若川

昆明醫科大學附一院甲狀腺疾病診治中心、云南省甲狀腺外科臨床研究中心（云南昆明 650031）;

Corresponding?author：

Keywords：

DOI：

10.7507/1007-9424.20160299

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 程若川. 2015年版較2009年版ATA指南對甲狀腺乳頭狀癌的手術治療變化及解讀. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(10): 1166-1168. doi: 10.7507/1007-9424.20160299 Copy

1.	Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA, 2015, 313(9):926-935.
2.	Rosário PW, Purisch S. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules. Arq Bras Endocrinol Metabol, 2010, 54(1):52-55.
3.	Kwak JY, Koo H, YoukJH, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology, 2010, 254(1):292-300.
4.	Leboulleux S, GirardE, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9):3590-3594.
5.	Frasoldati A, Valcavi R. Challenges in neck ultrasonography:lymphadenopathy and parathyroid glands. Endocr Pract, 2004, 10(3):261-268.
6.	Grant CS, Hay I, Gough ID, et al. Local recurrence in papillary thyroid carcinoma:is extent of surgical resection important? Surgery, 1988, 104(6):954-962.
7.	Matsuzu K, SuginoK, Masudo K, et al. Thyroid lobectomy for papillary thyroid cancer:long-term follow-up study of 1088 cases. World J Surg, 2014, 38(1):68-79.
8.	Barney BM, Hitchcock YJ, SharmaP, et al. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or totalthyroidectomy for differentiated thyroid cancer. Head Neck, 2011, 33(5):645-649.
9.	Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival:an analysis of 61775 patients. Ann Surg, 2014, 260(4):601-605.
10.	Hay ID, ThompsonGB, GrantCS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999):temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg, 2002, 26(8):879-885.
11.	American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1,Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214.
12.	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1):1-133.
13.	Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783.
14.	Popadich A, Levin O, Lee JC, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 2011, 150(6):1048-1057.
15.	Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11):1144-1152.
16.	Wang TS, Evans DB, Fareau GG, et al. Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer. Ann Surg Oncol. 2012, 19(13):4217-4222.
17.	Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958.
18.	Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm:implications for radioiodine treatment. J Clin Endocrinol Metab, 2009, 94(4):1162-1167.
19.	Laird AM, Gauger PG, Miller BS, et al. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg, 2012, 36(6):1268-1273.
20.	Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8):845-853.
21.	Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8):2706-2713.
22.	Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg today, 2013, 43(8):848-853.
23.	Lorente-Poch L, Sancho JJ, Ruiz S, et al. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg, 2015, 102(4):359-367.
24.	Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline:improving voice outcomes after thyroid surgery. Head Neck Surg, 2013, 148(6):S1-S37.
25.	Riemann B, Kramer JA, Schmid KW, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 2010, 49(3):79-84.
26.	Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma:a study of 34 patients. Mod Pathol, 2000, 13(2):123-130.
27.	高明. 甲狀腺結節和分化型甲狀腺癌診治指南. 中國腫瘤臨床, 2012, 33(17):1249-1272.
28.	中國抗癌協會甲狀腺癌專業委員會(CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識(2016版). 中國腫瘤臨床, 2016, 43(10):405-411.
29.	中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺及甲狀旁腺手術中神經電生理監測臨床指南(中國版). 中國實用外科雜志, 2013, 33(6):470-474.
30.	中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺手術中甲狀旁腺保護專家共識. 中國實用外科雜志, 2015, 35(7):731-736.

1. Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA, 2015, 313(9):926-935.
2. Rosário PW, Purisch S. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules. Arq Bras Endocrinol Metabol, 2010, 54(1):52-55.
3. Kwak JY, Koo H, YoukJH, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology, 2010, 254(1):292-300.
4. Leboulleux S, GirardE, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9):3590-3594.
5. Frasoldati A, Valcavi R. Challenges in neck ultrasonography:lymphadenopathy and parathyroid glands. Endocr Pract, 2004, 10(3):261-268.
6. Grant CS, Hay I, Gough ID, et al. Local recurrence in papillary thyroid carcinoma:is extent of surgical resection important? Surgery, 1988, 104(6):954-962.
7. Matsuzu K, SuginoK, Masudo K, et al. Thyroid lobectomy for papillary thyroid cancer:long-term follow-up study of 1088 cases. World J Surg, 2014, 38(1):68-79.
8. Barney BM, Hitchcock YJ, SharmaP, et al. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or totalthyroidectomy for differentiated thyroid cancer. Head Neck, 2011, 33(5):645-649.
9. Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival:an analysis of 61775 patients. Ann Surg, 2014, 260(4):601-605.
10. Hay ID, ThompsonGB, GrantCS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999):temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg, 2002, 26(8):879-885.
11. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1,Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214.
12. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1):1-133.
13. Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783.
14. Popadich A, Levin O, Lee JC, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 2011, 150(6):1048-1057.
15. Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11):1144-1152.
16. Wang TS, Evans DB, Fareau GG, et al. Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer. Ann Surg Oncol. 2012, 19(13):4217-4222.
17. Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958.
18. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm:implications for radioiodine treatment. J Clin Endocrinol Metab, 2009, 94(4):1162-1167.
19. Laird AM, Gauger PG, Miller BS, et al. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg, 2012, 36(6):1268-1273.
20. Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8):845-853.
21. Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8):2706-2713.
22. Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg today, 2013, 43(8):848-853.
23. Lorente-Poch L, Sancho JJ, Ruiz S, et al. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg, 2015, 102(4):359-367.
24. Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline:improving voice outcomes after thyroid surgery. Head Neck Surg, 2013, 148(6):S1-S37.
25. Riemann B, Kramer JA, Schmid KW, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 2010, 49(3):79-84.
26. Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma:a study of 34 patients. Mod Pathol, 2000, 13(2):123-130.
27. 高明. 甲狀腺結節和分化型甲狀腺癌診治指南. 中國腫瘤臨床, 2012, 33(17):1249-1272.
28. 中國抗癌協會甲狀腺癌專業委員會(CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識(2016版). 中國腫瘤臨床, 2016, 43(10):405-411.
29. 中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺及甲狀旁腺手術中神經電生理監測臨床指南(中國版). 中國實用外科雜志, 2013, 33(6):470-474.
30. 中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺手術中甲狀旁腺保護專家共識. 中國實用外科雜志, 2015, 35(7):731-736.

Previous Article
甲狀腺微小乳頭狀癌淋巴結轉移特點及處理策略
Next Article
甲狀腺微小乳頭狀癌的細針穿刺及手術時機的把握

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

2015年版較2009年版ATA指南對甲狀腺乳頭狀癌的手術治療變化及解讀

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content